NEXENTIS TECHNOLOGIES INC. Lease, Cost
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Lease, Cost of $80.50 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-03-27
- NEXENTIS TECHNOLOGIES INC. lease, cost for fiscal 2022 was $80.50K, a 85.70% increase from fiscal 2021.
- NEXENTIS TECHNOLOGIES INC. lease, cost for fiscal 2021 was $43.35K, a 5.81% increase from fiscal 2020.
- NEXENTIS TECHNOLOGIES INC. lease, cost for fiscal 2020 was $40.97K.
| Period end | Lease, Cost 12 month |
|---|---|
| 2022-12-31 | $80.50K 10-K · filed 2023-03-27 |
| 2021-12-31 | $43.35K 10-K · filed 2023-03-27 |
| 2020-12-31 | $40.97K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |